A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar Pustulosis

NCT04057937 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Palmoplantaris Pustulosis

Interventions

DRUG: Apremilast
DRUG: Placebo

Sponsor

Amgen